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Angel M. Pastor *† and Beatriz Benítez-Temiño †
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Extraocular motoneurons resist degeneration in diseases such as amyotrophic lateral
sclerosis. The main objective of the present work was to characterize the presence
of neurotrophins in extraocular motoneurons and muscles of the adult rat. We also
compared these results with those obtained from other cranial motor systems, such
as facial and hypoglossal, which indeed suffer neurodegeneration. Immunocytochemical
analysis was used to describe the expression of nerve growth factor, brain-derived
neurotrophic factor and neurotrophin-3 in oculomotor, trochlear, abducens, facial, and
hypoglossal nuclei of adult rats, and Western blots were used to describe the presence
of neurotrophins in extraocular, facial (buccinator), and tongue muscles, which are
innervated by the above-mentioned motoneurons. In brainstem samples, brain-derived
neurotrophic factor was present both in extraocular and facial motoneuron somata,
and to a lesser degree, in hypoglossal motoneurons. Neurotrophin-3 was present in
extraocular motor nuclei, while facial and hypoglossal motoneurons were almost devoid
of this protein. Finally, nerve growth factor was not present in the soma of any group
of motoneurons, although it was present in dendrites of motoneurons located in the
neuropil. Neuropil optical density levels were higher in extraocular motoneuron nuclei
when compared with facial and hypoglossal nuclei. Neurotrophins could be originated in
target muscles, sinceWestern blot analyses revealed the presence of the threemolecules
in all sampled muscles, to a larger extent in extraocular muscles when compared with
facial and tongue muscles. We suggest that the different neurotrophin availability could
be related to the particular resistance of extraocular motoneurons to neurodegeneration.
Keywords: brain-derived neurotrophic factor, neurotrophin-3, nerve growth factor, extraocular motoneurons,
facial, hypoglossal, cranial muscles, amyotrophic lateral sclerosis
INTRODUCTION
According to the trophic theory of neural connections enunciated by Purves (1990), neurons
depend on target-derived trophic support to survive during development. Also, neurotrophins are
key actors in the development and maintenance of adult phenotype (Mertz et al., 2000). Thus,
these molecules are implicated in regulatory pathways that mediate immature neuron survival
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(Oppenheim et al., 1992), proper development and migration
(Lindholm et al., 1997; Tanaka et al., 2000), as well as the
correct establishment of synaptic circuitries (Causing et al.,
1997; Morrison and Mason, 1998). Besides, in the adult,
neurotrophins have a role in the maintenance of neuron
morphological and electrophysiological characteristics, as well
as the adequate synaptic functionality, through the regulation
of neurotransmitter release and synaptic strength, and the
modulation of synaptic input pattern onto neurons (Gonzalez
and Collins, 1997; Desai et al., 1999; Novikov et al., 2000;
Davis-López de Carrizosa et al., 2009, 2010; Skaper, 2012). The
neurotrophin family of trophic factors is composed by four
different but structurally related proteins: nerve growth factor
(NGF, Levi-Montalcini, 1982), brain derived neurotrophic factor
(BDNF; Leibrock et al., 1989), neurotrophin 3 (NT-3; Jones and
Reichardt, 1990), and neurotrophin 4 (NT-4; Ip et al., 1992).
Neurotrophins are synthesized as pro-proteins, and then, they
may be spliced into the mature form, either before or after its
exocytosis. In fact, both pro-neurotrophins and their mature
forms have physiological effects. They participate in the control
of neuron homeostasis by interacting with two different types
of receptors. On one hand, neurotrophins may interact with
specific Trk receptors (Korsching, 1993; Barbacid, 1994). Thus,
dimers of NGF, BDNF, or NT-3 bind TrkA, TrkB, and TrkC,
respectively (Klein et al., 1991a,b; Lamballe et al., 1991). NT-4
binds TrkB (Ip et al., 1992), and NT3 may also bind TrkA and
TrkB, but with lower affinity. On the other hand, they might
interact with the low affinity p75 receptor (Chao and Hempstead,
1995). The interaction of neurotrophin dimers with Trk receptors
leads to receptor dimerization, reciprocal phosphorylation of
their intracellular tyrosine kinase domain, and the activation of
several downstream mechanisms implicated in the regulation of
the effects already explained above, including the maintenance of
the adult phenotype (Davis-López de Carrizosa et al., 2009).
Extraocular muscles (EOM) are formed by three
agonist/antagonist pairs that lead to eye movements around
three orthogonal axis of the eye (Büttner and Büttner-Ennever,
2006). In turn, EOM activity depends on motoneurons located
in three different brainstem nuclei: (i) the pontine abducens
nucleus (whose axons form the VI cranial nerve), (ii) the
ponto-mesencephalic trochlear nucleus (IV cranial nerve, and
(iii) the mesencephalic oculomotor nucleus (III cranial nerve)
(Büttner and Büttner-Ennever, 2006).
The majority of facial muscles are innervated by motoneurons
located in the pontine facial nucleus (VII cranial nerve), and
tongue muscle are innervated by motoneurons of the hypoglossal
nucleus (XII cranial nerve) located at the medulla oblongata.
The role of neurotrophins in the oculomotor system is
well documented (for review see Benitez-Temiño et al., 2016).
The three high affinity Trk receptors for neurotrophins are
expressed by motoneurons in the cat and rat oculomotor
system (Benítez-Temiño et al., 2004; Morcuende et al., 2011),
suggesting a strong neurotrophin influence on this population
of cells. Actually, in rats, the expression of Trk receptors
is modulated after lesion (Morcuende et al., 2011), and
neurotrophin administration to developing EOM motoneurons
reduces lesion-derived cell death (Morcuende et al., 2013).
Physiological actions of neurotrophins in the adult oculomotor
system have been revealed after exogenous administration to
cat axotomized extraocular motoneurons. Strikingly, BDNF and
NT-3 exhibit complementary actions on motoneuron firing rate:
while BDNF produces the recovery of a firing pattern related
to eye position, NT-3 seems to be more implicated in the
maintenance of the firing characteristics encoding eye velocity
(Davis-López de Carrizosa et al., 2009). NGF, on the other hand,
not only avoids the loss of eye-related signals after axotomy, but
it also increases firing rates and sensitivities to eye position and
velocity (Davis-López de Carrizosa et al., 2010).
Some of these data are surprising since, for instance, TrkA is
not expressed by other adult skeletal motoneuron populations
(Koliatsos et al., 1991, 1993; Merlio et al., 1992; Henderson
et al., 1993; Piehl et al., 1994; Tuszynski et al., 1996). This
peculiar relationship with neurotrophins in the adult might be
related to the particular resistance of extraocular motoneurons
to degeneration during the evolution of some diseases such
as ALS. However, it remains to be elucidated whether control
extraocular motoneurons are supplied with a higher quantity of
neurotrophins when compared with other motor populations. In
this project, we have pursued to investigate the actual relevance of
neurotrophins by comparing neurotrophin presence in resistant
(extraocular) as compared to sensitive (facial and hypoglossal)
brainstem motoneuron populations (Nimchinsky et al., 2000). In
addition, we have performedWestern blot analysis in extraocular,
buccinator and tongue muscles, innervated by extraocular, facial,
and hypoglossal motoneurons, in an attempt to determine the
possible origin of neurotrophins.
MATERIALS AND METHODS
Experiments were carried out in 13 adult Wistar rats weighing
∼250 g, 7 for immunocytochemistry and 6 for Western blot,
obtained from our breeding colony (Universidad de Sevilla). All
experimental procedures were in accordance with the European
Union Directive on the protection of animals used for scientific
purposes (2010/63/EU), and Spanish legislation (R.D. 53/2013,
BOE 34/11370-421) and the protocol was approved by the ethics
committee of the Universidad de Sevilla.
Immunocytochemistry
Deeply anesthetized animals (sodium pentobarbital, 35 mg/kg,
i.p.) were transcardially perfused with 100ml of 0.9% NaCl
followed by 250 ml of 4% paraformaldehyde in 0.1M sodium
phosphate buffer, pH 7.4. Brainstems were dissected, postfixed
for 2 h in the same fixative, and cryoprotected by immersion in a
solution of 30% sucrose in sodium phosphate buffer. The tissue
was then coronally cut at 40 µm thick sections on a cryostat
(Leica CM1850, Wetzlar, Germany) and stored in phosphate
buffered saline (PBS)-glycerol (1:1). Sections were randomly
selected for the immunostaining against each neurotrophin in the
different brainstem nuclei.
After several washes in PBS, sections were incubated in a
solution of 1% sodium borohydride for 10min to facilitate
antibody penetration. Tissue was then permeabilized in PBS
with 0.1% triton (PBS-T) for 30min, blocked with 10% normal
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donkey serum (NDS) in PBS-T, for 45 min, and incubated in
the corresponding primary antibody solution prepared at 1:400
in PBS-T + 5% NDS + 10% sodium azide for 12 h at room
temperature and under gentle agitation (rabbit anti-BDNF, sc-
546, rabbit anti-NT-3, sc-547, Santa Cruz Biotechnology, Dallas,
TX, USA).
In the case of the immunohistochemistry against NGF,
sections were previously incubated in citrate buffer pH 6, 0.01
M, at 40◦C for 40 min as an antigen retriever, rinsed in PBS and
blocked with 5% NDS in PBS-T at 37◦C for 30 min. Tissue was
then incubated in a solution containing the primary antibody
(rabbit anti-NGF, sc-548, Santa Cruz Biotechnology; 1:250 in
PBS-T+ 5% NDS+ 10% sodium azide), for 48 h at 4◦C.
Sections exposed to antibodies directed to either BDNF,
NT-3, or NGF were rinsed in PBS-T and incubated in a
biotinylated secondary antibody solution (donkey anti-rabbit,
Vector, Burlingame, CA; 1:500 in PBS-T) for 2 h, under agitation
and room temperature. Tissue was then washed several times
in PBS, and immersed for 45 min in a solution containing
Streptavidin Cy2 (Jackson ImmunoResearch, West Grove, PA,
USA; 1:400 in PBS).
Motoneurons were identified by immunohistochemistry
against choline acetyl transferase (ChAT). Briefly, sections were
thoroughly washed in PBS-T, blocked with 10% NDS in PBS-
T and incubated for 12 h and room temperature in a goat
anti-ChAT antibody solution (AB144P, Millipore, Temecula,
CA, USA), at 1:500 in PBS-T + 5% NDS + 10% sodium
azide. The antibody was then removed, and sections were
sequentially washed in PBS-T and incubated in a secondary
antibody coupled to TRITC (1:50 in PBS-T, donkey anti-goat,
Jackson InmunoResearch) for 2 h. After 3 washes in PBS, slices
were mounted on gelatinized glass slides and coverslipped with
mounting medium (n-propyl-gallate 0.1 M in PBS-glycerol 1:9).
After immunostaining, a scanning confocal microscope Zeiss
LSM 7 DUO (Carl Zeiss, Jena, Germany) was used to visualize
the tissue and to obtain and store images. The nuclei of
interest were anatomically identified using antibodies directed
against ChAT. Off-line image analysis was carried out using
ImageJ software (NIH, USA). Using images of Cy2-stained cells,
measures of optical density inside the cytoplasm of ChAT-
identified motoneurons were taken after BDNF and NT-3
immunostaining. Data were divided by the value of background
obtained in the same section. A cell was considered positive when
the neurotrophin staining intensity inside the soma was at least
five-fold the value of background.
The percentage of positive motoneurons for either BDNF or
NT-3 was obtained for each section in each nucleus, and mean
values were compared between nuclei (one-way ANOVA, overall
level of significance p < 0.05). The number of sampled cells
depended on the population size. Thus, for trochlear nuclei, the
number was between 84 and 117; for abducens nuclei, between
127 and 133; for oculomotor nuclei, between 381 and 468 cells;
for hypoglossal nuclei, between 437 and 443, and, finally, for
facial nuclei, we sampled 488–520 cells.
We found that NGF immunocytochemistry labeled only the
neuropil. Therefore, for measurements of NGF immunostaining
intensity we selected squared regions of 30.5µm side, and optical
density was calculated using the ImageJ software. Mean values
of NGF optical density were obtained for each nucleus, and
compared between the different nuclei (one-way ANOVA, overall
level of significance p < 0.05). Data correspond to mean± SEM.
Western Blot Analysis
Deeply anesthetized adult rats (sodium pentobarbital, 35 mg/kg,
i.p.) were decapitated and extraocular, buccinators, and tongue
muscles were dissected. Tissue was homogenized in ice-cold
lysis buffer containing a cocktail of proteases and phosphatase
inhibitors (10 mM Tris HCl, pH 7.5, 1% NP40, 150 mM NaCl, 1
mM phenylmethanesulfonyl fluoride -PMSF-, 1µg/ml aprotinin,
10 µg/ml chymostatin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 5
mM NaF, 20 mM sodium pyrophosphate -Ppi-, 1 mM Na3VO4).
After muscle disruption by sonication, tissue was centrifuged
at 13,000 rpm for 30 min. Total protein concentration in the
supernatant was determined by the Bradford method (Bradford,
1976), using bovine serum albumin (BSA) as a standard.
Proteins were diluted in sample buffer (62.5 mM Tris HCl,
pH 6.8, 10% glycerol, 10% SDS, 5% β-mercaptoethanol, 0.05%
bromophenol blue), denatured at 95◦C for 6 min, and then
separated by 15% SDS PAGE (50 µg/lane) and transferred to
polyvinylidene difluoride (PVDF) membranes by electroblotting.
After blockage of unspecific antigens with 5% BSA for 1 h, blots
were incubated overnight at 4◦C in a solution with antibodies
raised in rabbit against either NGF (1:500), BDNF (1:100), or
NT-3 (1:500) diluted in 0.1% TBS-Tween supplied with 5% BSA.
Membranes were then incubated in a solution containing the
HRP-conjugated anti-rabbit secondary antibody (1:3.000, Vector
Labs., Burlingame, CA, USA) prepared in TBS-Tween 0.1% for 90
min at room temperature. The immunoreactions were detected
with the Amersham ECL Western blotting kit (GE Healthcare
Life Sciences, UK).
Images from the bands were visualized on Image Reader LAS-
3000 (Fujifilm), stored and analyzed using Multi-Gauge V.3.0
software. Bands of mature and pro-form of neurotrophins were
obtained. For each membrane, data were expressed relative to
GAPDH values after background subtraction. Moreover, data
were normalized as percentages with respect to the values
obtained in the extraocular muscles. Mean values for each
neurotrophin and their pro-forms were calculated in each
muscle. Comparisons between muscles for the same protein
were carried out using one-way-ANOVA test (overall level of
significance p < 0.05).
RESULTS
Neurotrophin Presence in Oculomotor,
Trochlear, and Abducens Nuclei
Immunohistochemistry against ChAT allowed the unambiguous
identification of extraocular motoneurons, located in the
brainstem (oculomotor, trochlear, and abducens nuclei, shown
in Figure 1, first three rows). This method also allowed
distinguishing motoneurons from internuclear neurons, which
do not express ChAT.
The vast majority of extraocular motoneurons, located in
any of the three oculomotor-related nuclei, were positive for
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FIGURE 1 | Neurotrophin immunoreactivity in brainstem nuclei. Confocal microscopy images of oculomotor (OCM, A–E), trochlear (TRO, F–J), abducens (ABD, K–O),
facial (P–T), and hypoglossal (HYPO, U–Y) nuclei illustrating the presence of BDNF (first and second columns), NT-3 (third and fourth columns), and NGF (fifth column)
in brainstem motoneurons of adult rats. Motoneurons were identified by ChAT (red). Insets illustrate higher magnification images of neurotrophin-labeled motoneurons
in each nucleus. Arrows point to the motoneurons showed in the insets. Dashed lines in (K–O) delimit the genu of the facial nerve. Scale bars = 100 µm (in E for A–E,
in J for F–J, in O for K–O, in T for P–T, in X for W,X, and in Y for U,V, and Y). Inset scale bars = 25 µm.
BDNF and NT-3, as revealed by the presence of a diffuse
staining in the cytoplasm of extraocular motoneurons
(Figures 1A,F,K for BDNF, Figures 1C,H,M for NT-3).
Neither internal compartments in the cytoplasm nor plasmatic
membrane could be distinguished, although the nucleus
remained completely unstained (Figure 1, arrows). However,
neurotrophin-negative ChAT-identified motoneurons could
be scarcely observed. In contrast to BDNF and NT-3,
motoneuron somata were not stained against NGF. Instead,
NGF-positive dendrites, demonstrated in many instances as
originating from motoneuron cell bodies (Figures 2A–C), were
distributed throughout the neuropil (Figures 1E,J,O). The
three extraocular motor nuclei showed the same pattern of
staining.
Frontiers in Neuroscience | www.frontiersin.org 4 July 2017 | Volume 11 | Article 399
Hernández et al. Neurotrophin Expression in Brainstem Motor Systems
FIGURE 2 | ChAT-positive dendrites were stained using an antibody against
NGF. Confocal images of abducens (A–C), facial (D–F), and hypoglossal
(G–I) nuclei showing ChAT-positive dendrites (red) that colocalized with NGF
(green). Arrows point to NGF-positive dendrites connected to the soma of
ChAT-identified motoneurons (red). Arrowheads point to dendrite-like
ChAT-positive processes stained against NGF. Right column shows separately
the ChAT and NGF staining for the same dendrite. Scale bar = 25 µm.
Neurotrophin Presence in Facial and
Hypoglossal Nuclei
We also aimed to describe neurotrophin presence in brainstem
motor nuclei that result damaged during the degenerative
processes occurring in ALS. A high proportion of facial
motoneurons were positive for BDNF (Figures 1P,Q), with scarce
ChAT-positive BDNF-negative neurons distributed scattered in
the nucleus. On the contrary, only scant facial motoneurons
were positive for NT-3 (Figures 1R,S). No facial motoneuron
somata were positive for NGF, although, as was the case in
the oculomotor system, NGF-positive processes were found
throughout the neuropil (Figures 1T,2D–F).
Regarding hypoglossal motoneurons, rare cells were
positive for BDNF (Figures 1U,V) or NT-3 (Figures 1W,X).
Again, NGF-positive processes were detected in the neuropil
(Figures 1Y,2G–I). As described for extraocular motoneurons,
BDNF and NT-3, when present in facial and hypoglossal
motoneurons, were detected homogenously distributed in the
cytoplasm.
Quantitative Analysis of Neurotrophin
Staining Reveals Differences between
Oculomotor and Non-oculomotor Neurons
The percentage of positive cells with respect to the total number
of motoneurons within an extraoculomotor nucleus was similar
when compared between BDNF and NT-3. In the case of the
oculomotor nucleus, 95.9 ± 2.2% of motoneurons were BDNF-
positive (n = 381), while 89.4 ± 5.3% (n = 468) were positive
for NT-3. The percentage of positive motoneurons for BDNF and
NT-3 was 97.8 ± 1.1% (n = 84) and 95.8 ± 0.4% (n = 117),
respectively, in the trochlear nucleus, and 100% (n = 127) and
94.8 ± 2.95% (n = 133) in the abducens nucleus (Figures 3A,B,
blue bars). No significant differences were detected between the
neurotrophins BDNF or NT-3 either within the same nucleus
(t-test), or between the three extraoculomotor nuclei for the same
neurotrophin (one-way ANOVA test).
On the other hand, the quantitative analysis showed
differences between extraocular motoneurons, located in any of
the three extraoculomotor nuclei, and other brainstem motor
system motoneurons (Figure 3). As stated above, the percentage
of BDNF-positive and NT-3 positive motoneurons was similar in
the three extraocular nuclei (Figures 3A,B, blue bars). However,
although the percentage of BDNF-positive facial motoneurons
was also similar to that of extraocular motoneurons (87.6 ±
6.5%, n = 520), only 4.8 ± 2.1% (n = 443) of hypoglossal
motoneurons were positive for BDNF, which was significantly
different when compared with any of the other 4 nuclei (one-
way ANOVA test followed by Holm-Sidak method for multiple
pairwise comparisons, p < 0.001, Figure 3A). Regarding NT-
3, positive-motoneurons represented only a 3.2 ± 1.4% (n =
488) and a 0.2 ± 0.2% (n = 437) of facial and hypoglossal
motoneurons, respectively, which was significantly different from
values obtained in the extraocular nuclei (one-way ANOVA
test, followed by Holm–Sidak method for multiple pairwise
comparisons, p < 0.001, Figure 3B).
We also measured optical density in the neuropil of brainstem
sections immunostained against NGF. The optical density
values in the oculomotor, trochlear, and abducens nuclei were,
respectively, 21.4 ± 0.4, 20.0 ± 0.4, and 20.4 ± 0.5, which were
statistically similar between them (Figure 3C, blue columns).
Values obtained in the facial and hypoglossal nuclei (15.7 ±
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FIGURE 3 | Neurotrophin immunoreactivity is higher in extraocular than in
non-extraocular brainstem motoneurons. Quantification of the percentage of
BDNF (A) or NT-3 (B) immunopositive motoneurons and NGF staining in the
neuropil (C) of brainstem motor nuclei. Bars represent mean ± SEM. The
asterisks represent significant differences between groups (one-way ANOVA
test followed by Holm–Sidak method for multiple pairwise comparisons,
p < 0.001).
FIGURE 4 | Representative Western blots of tongue, buccinator and
extraocular muscles. Immunoblotting using antibodies against BDNF, NT-3,
and NGF in the muscles showed a positive labeling for both the
pro-neurotrophin (37, 35, and 27 kDa for BDNF, NT-3, and NGF, respectively)
and the mature forms (13 kDa). Other molecular weight isoforms also
appeared stained, probably representing immature forms of these trophic
factors. GAPDH immunoblotting was used as a loading control. EOM,
extraocular muscles.
0.4 and 17.6 ± 0.4, respectively) were significantly lower when
compared with those obtained in the oculomotor system (one-
way ANOVA test, followed by Holm–Sidak method for multiple
pairwise comparisons, p < 0.001, Figure 3C).
Presence of Neurotrophins in Cranial
Muscles
We studied the presence of neurotrophic factors, BDNF, NT-3,
and NGF, in the extraocular, buccinators and tongue muscles
of adult rats by means of protein immunoblot analysis. The six
extraocular muscles were processed in the same sample. We
found that the three neurotrophins were present in all muscles
analyzed. Bands of 13 kDa were obtained corresponding to
the mature forms of BDNF, NT-3, and NGF. Higher molecular
weight isoforms were also detected, corresponding to precursor
peptides. We focused in the pro-neurotrophin band, with a
molecular weight of 37, 35, and 27 kDa for BDNF, NT-3, and
NGF, respectively (Figure 4).
The total amount of BDNF, NT-3, and NGF protein was
quantified by densitometric analysis and values were normalized
to EOM data. Thus, EOM, compared to buccinator and tongue
muscles, presented a higher amount of mature BDNF (100, 38.3
± 7.5, 30.9 ± 9.0, Figure 5A), NT-3 (100, 45.7 ± 6.5, 29.1
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FIGURE 5 | Quantification of neurotrophin protein in the muscles. (A–C): Mature BDNF (A), NT-3 (B), and NGF (C) forms presented higher densitometric values in
extraocular muscles (EOM) than in buccinators (BUCC) or tongue muscles. (D–F): Immunoblot analysis of immature BDNF (D) and NGF (F) isoforms revealed no
differences between the three muscles. The amount of Pro-NT-3 (E) in extraocular muscles was larger than that observed in non-extraocular muscles.
(G–I): Mature/pro-form ratio for BDNF (G), NT-3 (H), and NGF (I). Note the ratio was lower than 1 for all neurotrophins in all muscles except for NT-3 in the EOM.
Asterisks represent significant differences with extraocular muscles, whereas the hashtag indicates differences with buccinator (one-way ANOVA test followed by
Holm–Sidak method for multiple pairwise comparisons, p < 0.001).
± 5.3, Figure 5B), and NGF protein (100, 39.4 ± 7.4, 51.4 ±
12.5, Figure 5C), respectively. The amount of pro-neurotrophin
in extraocular and non-extraocular muscles varied depending
on the neurotrophin tested. Thus, whereas no differences were
detected between the total amount of pro-BDNF in the three
samples (100, 157.3± 29.7, 228.0± 86.0, Figure 5D), NT-3 (100,
64.8 ± 7.5, 51.5 ± 7.6, Figure 5E), and NGF (100, 58.7 ± 20.5,
70.8 ± 16.9, Figure 5F) immature forms were significantly more
abundant in extraocular than in non-extraocular muscles (one-
way ANOVA test followed by Holm–Sidak method for multiple
pairwise comparisons, p < 0.001).
The statistical analysis of the mean ratio of the mature
and pro-form peptides of each neurotrophin demonstrated
an uppermost quantity of immature BDNF in the three
muscles studied, but we observed a significant smaller ratio
mature/immature in the non-extraocular muscles than in EOM
(0.7± 0.1, 0.2± 0.04, 0.1± 0.03, one-way ANOVA test followed
by Holm–Sidak method for multiple pairwise comparisons,
p < 0.001, Figure 5G). For NT-3, the ratio mature/pro-form
was similar between the different muscles (1.3 ± 0.3, 0.9
± 0.1, 0.8 ± 0.3, Figure 5H). Regarding NGF, we did not
find differences in the ratio mature/immature forms between
extraocular, buccinators, and tongue muscles (0.1 ± 0.04, 0.1 ±
0.02, 0.1 ± 0.02, Figure 5I). For NT-3 protein, we measured a
higher quantity of mature NT-3 isoform in the EOM, which was
not found in buccinator and tongue muscles (Figure 5H). In the
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case of NGF protein (Figure 5I), the amount of immature form
was higher than the immature form in all muscles.
DISCUSSION
The main objective of the present work was to reveal the
expression pattern of neurotrophins in the oculomotor system
of the adult rat, as well as to compare these results with those
obtained from other brainstem motor systems, such as facial and
hypoglossal. The present results show a rostro-caudal gradient
in neurotrophin expression in both innervating and target cells
(Figure 6). These results are in accordance with data obtained
from adult human (Tang et al., 2010) and rat brains (Li et al.,
2001) and muscles (Nosrat et al., 2000; Harandi et al., 2014).
The presence of the three neurotrophins in the adult
control oculomotor system is in good agreement with previous
results showing that extraocular motoneurons express the
three high affinity Trk receptors for neurotrophins (Benítez-
Temiño et al., 2004; Morcuende et al., 2013). In fact,
the exogenous administration of BDNF or NT-3 exerts
complementary physiological actions on axotomized adult
cat abducens motoneurons (Davis-López de Carrizosa et al.,
2009), and NGF restores and even increments the firing
pattern related to eye movements (Davis-López de Carrizosa
et al., 2010). Moreover, the present results show that, indeed,
neurotrophins are present constitutively in the adult oculomotor
system. Possible implications of neurotrophin expression in the
oculomotor system, and the relevance of the differences observed
with respect to other brainstemmotor nuclei, are discussed in the
following sections.
Presence of BDNF in Extraocular and
Facial but Not Hypoglossal Motoneurons
BDNF was present in almost all rat extraocular motoneurons,
located either in the oculomotor, trochlear or abducens nuclei.
Accordingly, BDNF was also present in the extraocular muscles.
The presence of BDNF in motoneuron somata is not a
direct indicator of the expression of the BDNF gene, since
it is well-known that neurotrophins may act via retrograde,
anterograde, paracrine, besides autocrine, pathways in motor
neurons (DiStefano et al., 1992; Korsching, 1993; Reynolds et al.,
2000). In the case of extraocular and facial motoneurons, it
must be considered that, first, BDNF protein and mRNA is
present in extraocular and buccinator muscles (Koliatsos et al.,
1993; Gómez-Pinilla et al., 2001) and in the neuromuscular
junction of extraocular muscles (Harandi et al., 2016), and
second, extraocular and facial motoneurons express the TrkB
receptor (Merlio et al., 1992; Yan et al., 1994; Morcuende et al.,
2013). Moreover, both populations are sensitive to retrogradely
administered BDNF after lesion (Yan et al., 1994; Davis-López
de Carrizosa et al., 2009). Consequently, BDNF protein present
in the motoneurons could have been synthesized by the target
muscle and retrogradely transported toward de soma.
However, it cannot be discarded that the BDNF present in
extraocular motoneurons could have other additional sources.
Thus, direct neurotrophin interaction with receptors located in
FIGURE 6 | Rostro-caudal gradient of neurotrophin influence in the analyzed
brainstem motor systems. The scheme shows neurotrophin immunoreactivity
pattern in motoneurons and muscles belonging to the oculomotor system
(blue), facial motor system (yellow), and hypoglossal motor system (red). Note
that neurotrophins are less abundant as motor systems are located more
caudally in the brainstem, both in terms of neurotrophin diversity
(motoneurons) or quantity (muscles). C, Caudal; R, Rostral.
the soma or dendrites of both developing and mature neurons
have already been described, demonstrating anterograde (Von
Bartheld et al., 1996; Fawcett et al., 1998), paracrine (Robinson
et al., 1996), and even autocrine (Miranda et al., 1993; Acheson
et al., 1995; Davies, 1996; Buck et al., 2000) actions of BDNF.
Regarding facial motoneurons, although the percentage of
immunopositive-cells was similar to that obtained in the
extraocular motor system, our results show that the amount of
BDNF protein in the facial muscle was lower than that observed
in extraocular muscles, and the ratio mature/pro-BDNF was
lower, indicating a higher quantity of the immature form of
BDNF in the buccinator muscle, which has a lesser ability to
activate the TrkB pathway than the mature form (Mowla et al.,
2001). Therefore, other possible sources of BDNF for facial
motoneurons should also be considered. In fact, it has been
postulated that neurotrophins arriving to different compartments
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of the cell could participate in different cell functions (Heerssen
and Segal, 2002), so different sources of neurotrophins would not
be redundant.
Regarding the anterograde pathway, two major afferences
to extraoculomotor nuclei arise from pontine and medullary
vestibular and prepositus hipoglossi neurons (Büttner and
Büttner-Ennever, 2006). The presence of BDNF protein and
the expression of the mRNA have been demonstrated in adult
rat vestibular and prepositus neurons (Li et al., 2001). Since
vestibular cells also project toward facial motoneurons (Shaw and
Baker, 1983), they could also serve as an anterograde source of
neurotrophins for these cells.
Besides, BDNF could have a paracrine origin. In this case,
glial cells are the main candidates, since BDNF is released by
astrocytes under control conditions (Takemoto et al., 2015).
However, although in the present study a clear identification of
glial cells was not performed, we did not observe any BDNF
positive-cell that could resemble the shape and size of astrocytes
or microglia, suggesting that glia is probably not an important
source of BDNF in oculomotor or facial motor systems. Finally,
the origin of BDNF could be autocrine, as suggested for spinal
motoneurons (Nishio et al., 1998). However, further research is
needed to test whether neurotrophin mRNA synthesis occurs in
motoneurons located at the facial and extraocular motor nuclei.
Taken together, present and previous data suggest
that even considering other alternative sources of
neurotrophins, retrograde BDNF is needed for extraocular
motoneurons to maintain their normal adult properties
(Davis-López de Carrizosa et al., 2009). In contrast, the
anterograde/paracrine/autocrine routes seem to be necessary to
explain the presence of BDNF in facial motoneurons.
On the other side, the vast majority of hypoglossal
motoneurons were BDNF immunonegative. These cells only
express the NT-3 receptor, TrkC, but neither TrkA nor TrkB
(Merlio et al., 1992), and thus are likely insensitive to BDNF.
In fact, BDNF protein present in the muscle could have not
been originated in tongue muscle fibers, since no BDNF mRNA
has been found in these muscle fibers, whereas sensitive taste
buds do express this neurotrophin (Nosrat et al., 2000), so its
function in the tongue could be independent of the tongue
motor system. Although, special care was taken to avoid taste
buds inclusion in the samples, the possibility of some degree of
contamination cannot be discarded. Another possibility is that
tongue BDNF has an endothelial origin, as vascular endothelial
cells express this trophic factor (Nakahashi et al., 2000). If this
was the case, then BDNF protein present in tongue muscle fibers
could have a paracrine origin, and its function would be restricted
to the muscle, and not to hypoglossal motoneurons. However,
and in opposition to this hypothesis, retrograde transport of
exogenous BDNF can restore ChAT expression in axotomized
hypoglossal motoneurons (Wang et al., 1997), indicating that, at
least after axotomy, this neurotrophin is trophic for hypoglossal
motoneurons.
NT-3 Is Present in the Extraocular Motor
System
As was the case for BDNF, NT-3 was present in most of
extraocularmotoneurons, as well as in EOM. These data, together
with the facts that, first, extraocular motoneurons express TrkC
(Morcuende et al., 2011), and second, retrogradely-driven NT-3
is necessary to maintain certain motoneuron properties (Davis-
López de Carrizosa et al., 2009), indicate a retrograde action
of NT-3 in the extraocular motor system. These results are in
accordance with those obtained by Harandi et al. (2014, 2016),
in which they described NT-3 expression in EOM and NT-3
presence at the neuromuscular junction of EOM obtained from
control mice.
Only scarce facial motoneurons, and no hypoglossal
motoneuron, were immunoreactive to NT-3, even though
both populations express the high affinity receptor for NT-3
(Merlio et al., 1992), and NT-3 was present in both target
muscles (buccinator and tongue muscles, respectively), although
to a lower extent when compared with EOM. The most likely
explanation of this apparent contradiction between the extremely
low presence of NT-3 in facial and hypoglossal motoneurons,
compared with their respective muscles, is that muscle-derived
NT-3 could bind TrkC receptors located in the axon terminal
and exert its function locally at the axonal level, without being
transported to the soma, or that muscle-derived NT-3 might
signal the cell body through intermediary effector molecules.
However, in agreement with these results, a scarce or null effect
of exogenous NT-3 in regulating ChAT expression has been
shown after facial or hypoglossal nerve section (Tuszynski et al.,
1996; Fernandes et al., 1998). These results would imply a low
responsiveness of these motoneurons to NT-3.
Thus, the fact that, first, NT-3 is more abundant in EOM
muscles than in tongue or buccinator muscles, and second, this
neurotrophin in necessary for the maintenance of extraocular
motoneuron adult characteristics (Davis-López de Carrizosa
et al., 2009), could point to a higher relevance of retrogradely-
driven NT-3 in the maintenance of oculomotor function, when
compared with the other two motor systems.
NGF Is Present in the Neuropil of
Brainstem Motor Nuclei
The antibody against NGF produced a pattern of labeling that
differed radically from that obtained against the other two
neurotrophins. In the five nuclei analyzed, NGF was absent from
motoneuron somata. Instead, long NGF-positive, dendrite-like
processes could be observed dispersed throughout the nucleus
neuropil and in several instances could be demonstrated arising
from motoneurons.
Facial and hypoglossal motoneurons, like spinal
motoneurons, do not express the TrkA receptor (Koliatsos
et al., 1991, 1993; Merlio et al., 1992; Henderson et al., 1993;
Piehl et al., 1994; Tuszynski et al., 1996). Considering the low
levels of mature NGF found in the buccinator and tongue
muscles, together with the lack of TrkA expression by their
innervating motoneurons, the absence of NGF in facial and
hypoglossal motoneurons somata is not surprising. On the
contrary, experiments using immunohistochemistry and in situ
hybridization in extraocular motoneurons have shown not only
TrkA expression under control conditions (Benítez-Temiño
et al., 2004; Morcuende et al., 2011), but also a modulation of its
expression in response to axotomy (Morcuende et al., 2011). The
amount of mature NGF in EOM was higher than that observed
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in buccinator and tongue muscles. Thus, we would expect to find
retrogradely-transported NGF in extraocular motoneuron soma.
In accordance with this hypothesis, extraocular motoneurons
have been proven to be sensitive to NGF after axotomy and
exogenous administration of this neurotrophin through their
proximal axonal stumps (Davis-López de Carrizosa et al.,
2010).
Regarding the possible origin of the NGF observed in the
neuropil, this neurotrophin could arise from different unknown
sources. On one side, NGF positive-processes could belong to
astrocytic or microglial cells, that express constitutively this
neurotrophin (Sofroniew et al., 2001). However, the shape
and the size of NGF-positive processes were not indicative of
glial origin. On the other, NGF could follow an anterograde
route, being expressed at extraocular, facial and hypoglossal
afferences. Finally, NGF could be synthesized by motoneurons
and released from their dendrites acting trophically to afferences.
Indeed, our data suggest this possibility due to the colocalization
observed in motoneuron dendrites between ChAT and NGF.
In comparison with facial and hypoglossal nuclei, the present
results show a stronger staining after NGF immunocytochemistry
in the extraoculomotor nuclei. These data, together with the
constitutive expression of TrkA in extraocular motoneurons–a
receptor that is not present in other motoneuronal types-, point
to a higher potentiality of NGF as a physiological and metabolic
mediator of oculomotor function when compared with facial and
hypoglossal motor systems.
Possible Influence of Neurotrophins in the
Resistance to ALS of Extraocular
Motoneurons
ALS affects mainly motoneurons, with no discrimination
between cranial or spinal positions. However, brainstem
motoneurons innervating extraocular muscles, and sacral
motoneurons projecting on pelvic floor muscles, exhibit a
much stronger resistance to degeneration (Ohki et al., 1994;
Nimchinsky et al., 2000). This particular resistance might be due
to distinct, special features affecting motoneurons, their target
muscles, or both. Unrevealing these possible differences could
represent an important step toward the understanding of ALS
neurodegenerative mechanisms, opening new lines of research to
improve motoneuron survival.
Interestingly, the oculomotor system is also different from
other motor systems in its sensitivity to neurotrophins. Thus,
only extraocular motoneurons express the TrkA receptor
for NGF, which is absent from other brainstem and spinal
motoneurons (Koliatsos et al., 1991, 1993; Merlio et al., 1992;
Henderson et al., 1993; Piehl et al., 1994; Tuszynski et al.,
1996). Extraocular motoneurons also respond to neurotrophins
after lesion by recovering their normal discharge activity
and synaptic inputs (Davis-López de Carrizosa et al., 2009,
2010). Due to the well-known ability of neurotrophins to
increase motoneuron survival during development and after
lesion, trophic factors are good candidates to be implicated
in motoneuron survival/degeneration during the progression
of ALS.
In fact, post-mortem analysis of spinal cords obtained from
ALS patients have demonstrated a decreased amount of NT-
3 and BDNF in spinal motoneurons (Duberley et al., 1997;
Nishio et al., 1998), as well as an increase in the quantity of
non-phosphorylated TrkB (Mutoh et al., 2000), pointing to a
diminution in trophic signaling in degenerating motoneurons
during ALS progression in humans. It would be interesting to
elucidate whether extraocular motoneurons alter neurotrophin
expression during ALS progression, or instead maintain their
BDNF and NT-3 signaling.
The effect of exogenous neurotrophin administration in ALS
murine models also highlights the potential therapeutic use
of these molecules, although paradoxical results obtained by
different groups invite to be critical. Thus, while some groups
have reported neither effects of BDNF and NT-3 on motoneuron
survival when exposed to glutamate toxicity in culture (Corse
et al., 1999), nor an increase in lifespan in ALS mouse models
(Park et al., 2009), other groups have demonstrated an improved
motor function and an increased survival of motoneurons
treated with BDNF or NT-3 in different murine models of ALS
(Mitsumoto et al., 1994; Ikeda et al., 1995; Haase et al., 1997; Kaal
et al., 1997). However, neurotrophin therapy in ALS patients has
not revealed to be useful in the treatment of this disease (Bradley,
1999; Ochs et al., 2000; Henriques et al., 2010).
Altogether, due to the numerous trophic effects described
for neurotrophins in motoneurons, and considering that, first,
extraocular motoneurons and muscles are enriched in these
molecules in contrast to other cranial motor systems, and,
second, that extraocular motoneurons are less vulnerable to
ALS, we suggest that the high presence of neurotrophins in
the extraoculomotor system might be linked to their higher
resistance to this disease.
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